Jump to main content
Jump to site search

Issue 5, 2018
Previous Article Next Article

Cell imaging of dopamine receptor using agonist labeling iridium(III) complex

Author affiliations

Abstract

Dopamine receptor expression is correlated with certain types of cancers, including lung, breast and colon cancers. In this study, we report luminescent iridium(III) complexes (11–14) as intracellular dopamine receptor (D1R/D2R) cell imaging agents. Complexes 11 and 13, which are conjugated with a dopamine receptor agonist, showed superior cell imaging characteristics, high stability and low cytotoxicity (>100 μM) in A549 lung cancer cells. siRNA knockdown and dopamine competitive assays indicated that complexes 11 and 13 could selectively bind to dopamine receptors (D1R/D2R) in A549 cells. Fluorescence lifetime microscopy demonstrated that complex 13 has a longer luminescence lifetime at the wavelength of 560–650 nm than DAPI and other chromophores in biological fluids. The long luminescence lifetime of complex 13 not only provides an opportunity for efficient dopamine receptor tracking in biological media, but also enables the temporal separation of the probe signal from the intense background signal by fluorescence lifetime microscopy for efficient analysis. Complex 13 also shows high photostability, which could allow it to be employed for long-term cellular imaging. Furthermore, complex 13 could selectively track the internalization process of dopamine receptors (D1R/D2R) in living cells. To the best of our knowledge, complex 13 is the first metal-based compound that has been used to monitor intracellular dopamine receptors in living cells.

Graphical abstract: Cell imaging of dopamine receptor using agonist labeling iridium(iii) complex

Back to tab navigation

Supplementary files

Publication details

The article was received on 06 Nov 2017, accepted on 09 Dec 2017 and first published on 19 Dec 2017


Article type: Edge Article
DOI: 10.1039/C7SC04798C
Citation: Chem. Sci., 2018,9, 1119-1125
  • Open access: Creative Commons BY license
  •   Request permissions

    Cell imaging of dopamine receptor using agonist labeling iridium(III) complex

    K. Vellaisamy, G. Li, C. Ko, H. Zhong, S. Fatima, H. Kwan, C. Wong, W. Kwong, W. Tan, C. Leung and D. Ma, Chem. Sci., 2018, 9, 1119
    DOI: 10.1039/C7SC04798C

    This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. Material from this article can be used in other publications provided that the correct acknowledgement is given with the reproduced material.

    Reproduced material should be attributed as follows:

    • For reproduction of material from NJC:
      [Original citation] - Published by The Royal Society of Chemistry (RSC) on behalf of the Centre National de la Recherche Scientifique (CNRS) and the RSC.
    • For reproduction of material from PCCP:
      [Original citation] - Published by the PCCP Owner Societies.
    • For reproduction of material from PPS:
      [Original citation] - Published by The Royal Society of Chemistry (RSC) on behalf of the European Society for Photobiology, the European Photochemistry Association, and RSC.
    • For reproduction of material from all other RSC journals:
      [Original citation] - Published by The Royal Society of Chemistry.

    Information about reproducing material from RSC articles with different licences is available on our Permission Requests page.

Search articles by author

Spotlight

Advertisements